RxDoctor Payments Data

Evan Lau, MD

Interventional Cardiology · Springfield, MANPI 1508992280

Payments from drug & device makers

$2,016in general payments, 2019–2025

Across 39 payments — averaging $51.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Abbott$580
  • Cardiovascular Systems Inc.$150
  • Edwards Lifesciences$28
  • Terumo Medical Corporation$20

What the payments were for

  • Travel & lodging$28014%
  • Food & beverage$1,73686%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,016 in reported general payments places this provider in the 30th percentile of 128 interventional cardiology providers in Massachusetts.

See all interventional cardiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$267,323
Medicare patients
645
Services billed
1,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban158$171,758
EntrestoSacubitril/Valsartan157$159,660
XareltoRivaroxaban52$42,709
FarxigaDapagliflozin Propanediol53$39,181
Repatha SureclickEvolocumab32$27,764
BrilintaTicagrelor26$21,379
Icosapent Ethyl17$6,221
Metoprolol Succinate366$5,952
Atorvastatin Calcium318$5,725
Ezetimibe89$4,603
Rosuvastatin Calcium103$4,081
Eplerenone17$2,212
Valsartan35$1,339
Amlodipine Besylate127$1,209
Carvedilol106$1,148

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →